FBXO32 and muscle atrophy: In models of muscle atrophy, reduced Akt pathway activity leads to nuclear accumulation of FoxO proteins, promoting the expression of Atrogin-1/MAFbx and MuRF1, thereby accelerating protein degradation (126, 127, 129).